Evaluation of a novel university-based testing platform to increase access to SARS-CoV-2 testing during the COVID-19 pandemic in a cohort study.

Julia Catherine BennettJessica O'HanlonZachary AckerPeter D HanDevon McDonaldTessa WrightKyle G LuitenLani RegelbruggeKathryn M McCaffreyBrian PfauCaitlin R WolfGeoffrey S GottliebJames P HughesMarco CaroneLea M StaritaHelen Y ChuAna A Weil

Published in: BMJ open (2024)

Unsupervised swab collection permitted increased testing when demand was high, allowed for access to a broader proportion of the university community and was not associated with a substantial increase in testing errors.

Keyphrases

sars cov
healthcare
machine learning
respiratory syndrome coronavirus
adverse drug